CAMBRIDGE, Mass., July 18, 2008 (PRIME NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will report its financial results for the second quarter ended June 30, 2008 before the U.S. financial markets open on Thursday, July 24, 2008.
